Pay in 4 interest-free payments of $6.95 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Because it activates both, it's often called a "dual agonist." The FDA has described tirzepatide (brand name Zepbound) as the first medication of its kind to activate both of these receptors for weight management, and it was approved for that use in November 2023
Thats not good for you
A nu se lsa la ndemana i la vederea copiilor mici
M25.512 Pain in left shoulder
While the drug has proven effective for these purposes, concerns have emerged regarding its side effects
US$ 28.16
US$ 21.12
US$ 21.67
US$ 29.76
US$ 29.05
US$ 27.40
US$ 23.65
![Structures of (a) GLP-1, (b) GIP and (c) tirzepatide [19, 88, 90]](https://www.researchgate.net/publication/370926483/figure/fig4/AS:11431281185432337@1693619320519/Structures-of-a-GLP-1-b-GIP-and-c-tirzepatide-19-88-90-Amino-acids-are.png)
US$ 28.68
